Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune response to elicit its effector function. They have shown to be highly specific and safe, but have yet to prove themselves as an efficacious treatment for cancer in the clinic. This is for a variety of reasons, incl...

Bibliografiset tiedot
Päätekijät:	Stephens, AJ, Burgess-Brown, NA, Jiang, S
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Frontiers Media 2021

Samankaltaisia teoksia

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Tekijä: Alexander J. Stephens, et al.
Julkaistu: (2021-06-01)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
Tekijä: Xiao Wei, et al.
Julkaistu: (2019-05-01)

Adrenomedullin: Not Just Another Gastrointestinal Peptide
Tekijä: Sonia Martínez-Herrero, et al.
Julkaistu: (2022-01-01)

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
Tekijä: Jennifer Pfeil, et al.
Julkaistu: (2021-08-01)

Peptide Vaccines for Cancer
Tekijä: Kono K
Julkaistu: (2013-10-01)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
Tekijä: Ahmed O. Shalash, et al.
Julkaistu: (2022-04-01)

Adjuvants for peptide-based cancer vaccines
Tekijä: Willem W Overwijk, et al.
Julkaistu: (2016-09-01)

Peptide-based vaccine for cancer therapies
Tekijä: Luigi Buonaguro, et al.
Julkaistu: (2023-08-01)

Presentation of antigenic peptides by products of the major histocompatibility complex.
Tekijä: Fairchild, P
Julkaistu: (1998)

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine
Tekijä: Chan, S
Julkaistu: (2022)

Role of Linker Length and Antigen Density in Nanoparticle Peptide Vaccine
Tekijä: Chintan H. Kapadia, et al.
Julkaistu: (2019-03-01)

Corrigendum: Peptide-based vaccine for cancer therapies
Tekijä: Luigi Buonaguro, et al.
Julkaistu: (2023-10-01)

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
Tekijä: Li Ou, et al.
Julkaistu: (2022-11-01)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
Tekijä: Douglas McNeel, et al.
Julkaistu: (2023-11-01)

Low-complexity sequences and single amino acid repeats: not just "junk" peptide sequences.
Tekijä: Haerty, W, et al.
Julkaistu: (2010)

TEIPP peptides: exploration of unTAPped cancer antigens
Tekijä: Koen A. Marijt, et al.
Julkaistu: (2019-08-01)

In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients
Tekijä: San Jiun Chai, et al.
Julkaistu: (2019-01-01)

Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination
Tekijä: Markus Haug, et al.
Julkaistu: (2018-04-01)

Peptide Vaccine Therapy in Colorectal Cancer
Tekijä: Shi-Yu Yang, et al.
Julkaistu: (2012-08-01)

Peptide-Based Immunotherapeutics and Vaccines
Tekijä: Pedro A. Reche, et al.
Julkaistu: (2014-01-01)

Peptide-Based Vaccines for Tuberculosis
Tekijä: Wenping Gong, et al.
Julkaistu: (2022-01-01)

Potential association factors for developing effective peptide-based cancer vaccines
Tekijä: Chongming Jiang, et al.
Julkaistu: (2022-07-01)

Overlapping synthetic peptides as vaccines
Tekijä: Jiang, S, et al.
Julkaistu: (2006)

Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants
Tekijä: Gandharva Nagpal, et al.
Julkaistu: (2018-07-01)

Peptide‐Based Cancer Vaccine Delivery via the STINGΔTM‐cGAMP Complex
Tekijä: He, Yanpu, et al.
Julkaistu: (2022)

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era
Tekijä: Koollawat Chupradit, et al.
Julkaistu: (2017-09-01)

Antigen presentation. Naturally processed peptides.
Tekijä: Elliott, T, et al.
Julkaistu: (1990)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
Tekijä: Jennifer Pfeil, et al.
Julkaistu: (2020-10-01)

Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Tekijä: Kunal Nepali, et al.
Julkaistu: (2022-09-01)

1040-H Coupling DNA barcoding and multi-peptide screening: unveiling T cell receptor and antigenic peptide relationships in complex samples
Tekijä: Miranda Byrne-Steele, et al.
Julkaistu: (2023-11-01)

Synthetic peptide vaccines
Tekijä: O. V. Sergeyev, et al.
Julkaistu: (2016-02-01)

Peptide Vaccines for Leishmaniasis
Tekijä: Rory C. F. De Brito, et al.
Julkaistu: (2018-05-01)

Peptide-Based Immunotherapeutics and Vaccines 2017
Tekijä: Pedro Reche, et al.
Julkaistu: (2018-01-01)

Peptide-Based Immunotherapeutics and Vaccines 2015
Tekijä: Pedro Reche, et al.
Julkaistu: (2015-01-01)

Antitumor Peptide-Based Vaccine in the Limelight
Tekijä: Takumi Kumai, et al.
Julkaistu: (2022-01-01)

Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges
Tekijä: Reid M. Rubsamen, et al.
Julkaistu: (2024-02-01)

MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
Tekijä: Cunha-Neto E.
Julkaistu: (1999-01-01)

Light control of the peptide-loading complex synchronizes antigen translocation and MHC I trafficking
Tekijä: Jamina Brunnberg, et al.
Julkaistu: (2021-03-01)

Chaperone-mediated MHC-I peptide exchange in antigen presentation
Tekijä: Jiansheng Jiang, et al.
Julkaistu: (2024-05-01)

Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide.
Tekijä: Amy X Yang, et al.
Julkaistu: (2014-01-01)